ASSISTANT PROFESSOR, PHD, UNIVERSITY OF TORONTO 2012
Dr. Christine Chio is a new junior faculty at the Institute of Cancer Genetics. Dr. Chio received her PhD from the University of Toronto under the mentorship of Dr. Tak Wah Mak, studying the interplay between inflammation and cancer development. Subsequently, she joined the lab of Dr. David Tuveson at Cold Spring Harbor Laboratory to pursue her postdoctoral training. Since then, her research endeavor has focused on understanding the role of cellular redox regulation, particularly in the development of pancreatic ductal adenocarcinoma (PDA).
JUNIOR RESEARCH SCIENTIST, BSC, NEW YORK UNIVERSITY 2017
Dana studies the role of mitochondrial NADPH in pancreatic cancer progression.
JUNIOR RESEARCH SCIENTIST, BSC, EMORY UNIVERSITY 2017
Karina studies eIF4A-dependent translational regulation in pancreatic cancer.
Marina Ayres Pereira
POSTDOCTORAL FELLOW, PHD, COPENHAGEN, DENMARK
Marina received her PhD from the University of Copenhagen, under the supervision of Dr. Ali Salanti. During her studies, she characterizeddistinctly sulfated glycosaminoglycans involved in cancer progression and placental malaria. Subsequently, she was involved in a project aiming at the development of a platform to capture circulating tumour cells from a liquid biopsy using a recombinant malaria protein, VAR2CSA. In the Chio Lab, her focus is on the identification of disease-relevant regulatory mechanisms in mRNA translation and protein stability that promote pancreatic cancer progression and metastasis.
PhD CANDIDATE, BSC, UCSD 2018
Sherry graduated from University of California, San Diego. During her studies, she worked in Dr. Susan Taylor’s lab where she characterized a mutant form of Protein Kinase A. Subsequently, she joined Dr. Clodagh O’Shea’s lab in Salk Institute and was involved in a project aiming at the development of an engineered adenovirus as a novel treatment for cancer. In the Chio Lab, she will investigate the role of redox signalling in the process of pancreatic tumorigenesis.